Publicacions
-
Colmenero M, Del Boz J, Bernabeu Wittel J, Roé E, Feito-Rodríguez M, Vicente-Villa MA, Martín-Santiago A, Palencia Pérez SI, Azon A, Valdivielso-Ramos M, Torrelo A, Sánchez Moya AI, Campos-Domínguez M, Garnacho-Saucedo G, Azaña Defez JM, Vera Casaño Á, Tercedor-Sánchez J, Alcalá R, González-Enseñat MA, Giacaman A, Hernández-Martin Á, Monserrat García MT, Bauzá A, Domínguez-Cruz J, García-Doval I and Grau-Pérez M.
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain
PEDIATRIC DERMATOLOGY . 39(4): 557-562. Nº de cites: 3
-
Baselga E, El Hachem M, Diociaiuti A, Carnevale C, Downey C, Roe E, Mascaro P, Neri I, Leuzzi M, Bernabeu-Wittel J, Monserrat-García MT, Ortiz-Prieto A, Torrelo A, Knopfel N, Vercellino N, Manunza F, Oranges T, Bassi A, González-Enseñat MA, Vicente-Villa MA, Gich I and Puig L.
Sequelae following infantile haemangiomas treated with propranolol
EUROPEAN JOURNAL OF DERMATOLOGY . 31(6): 785-790. Nº de cites: 6
-
Carrascosa JM, de la Cueva P, de Lucas R, Fonseca E, Martín A, Vicente-Villa MA, Fortes MP, Gómez S and Rebollo FJ.
Patient Journey in Atopic Dermatitis: The Real-World Scenario
Dermatology and Therapy . 11(5): 1693-1705. Nº de cites: 7
-
Cuenca-Barrales C, Baselga E, Del Boz-González J, Vicente-Villa MA, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I and Bernabéu-Wittel J.
Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data
ACTAS DERMO-SIFILIOGRAFICAS . 112(9): 806-816. Nº de cites: 3
-
Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.
Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children
PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de cites: 8
-
Valdivielso-Ramos, M, Martin-Santiago, A, Azana, JM, Hernandez-Nunez, A, Vera, A, Perez, B, Tercedor, J, Feito, M, Vicente-Villa MA, Prat-Torres CS, Lopez-Gutierrez, JC, Garnacho, G, Baselga E, Roe, E, Palencia, S, Cordero, P, Moreno, R, Agudo, A, de la Cueva, P and Torrelo, A.
Capillary malformation-arteriovenous malformation syndrome: a multicentre study
CLINICAL AND EXPERIMENTAL DERMATOLOGY . 46(2): 300-305. Nº de cites: 28
-
Martín-Nalda A, Fortuny-Guasch C, Rey L, Bunney TD, Alsina L, Esteve-Solé A, Bull D, Anton MC, Basagaña M, Casals F, Deyá A, García-Prat M, Gimeno R, Juan-Otero M, Martinez-Banaclocha H, Martinez-Garcia JJ, Mensa-Vilaró A, Rabionet-Janssen R, Martin-Begue N, Rudilla F, Yagüe-Ribes J, Estivill X, García-Patos V, Pujol RM, Soler-Palacín P, Katan M, Pelegrín P, Colobran R, Vicente-Villa MA and Arostegui-Gorospe JI.
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
JOURNAL OF CLINICAL IMMUNOLOGY . 40(7): 987-1000. Nº de cites: 38
-
Gálvez V, Chacón-Solano E, Bonafont J, Mencía Á, Di WL, Murillas R, Llames S, Vicente-Villa MA, Del Rio M, Carretero M and Larcher F.
Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome
Molecular Therapy-Methods & Clinical Development . 18: 280-290. Nº de cites: 14
-
Gadea A, Hernandez-Muñoz MI, Vicente-Villa MA, Andrades E, García-Calvente M, Camacho L, Fernandez-Rodríguez C, Bellosillo B, Pujol R and Toll A.
Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.
JOURNAL OF MEDICAL GENETICS . 57(9): 601-604. Nº de cites: 3
-
Esperón-Moldes U, Ginarte-Val M, Rodríguez-Pazos L, Fachal L, Martín-Santiago A, Vicente-Villa MA, Jiménez-Gallo D, Guillén-Navarro E, Sampol LM, González-Enseñat MA and Vega A.
Novel CYP4F22 mutations associated with autosomal recessive congenital ichthyosis (ARCI). Study of the CYP4F22 c.1303C>T founder mutation
PLoS One . 15(2): . Nº de cites: 14